Tracking Drug-Induced Epithelial-Mesenchymal Transition in Breast Cancer by a Microfluidic Surface-Enhanced Raman Spectroscopy Immunoassay.

Small
Zhen ZhangMatt Trau

Abstract

Epithelial-mesenchymal transition (EMT) is a primary mechanism for cancer metastasis. Detecting the activation of EMT can potentially convey signs of metastasis to guide treatment management and improve patient survival. One of the classic signatures of EMT is characterized by dynamic changes in cellular expression levels of E-cadherin and N-cadherin, whose soluble active fragments have recently been reported to be biomarkers for cancer diagnosis and prognosis. Herein, a microfluidic immunoassay (termed "SERS immunoassay") based on sensitive and simultaneous detection of soluble E-cadherin (sE-cadherin) and soluble N-cadherin (sN-cadherin) for EMT monitoring in patients' plasma is presented. The SERS immunoassay integrates in situ nanomixing and surface-enhanced Raman scattering readout to enable accurate detection of sE-cadherin and sN-cadherin from as low as 10 cells mL-1 . This assay enables tracking of a concurrent decrease in sE-cadherin and increase in sN-cadherin in breast cancer cells undergoing drug-induced mesenchymal transformation. The clinical potential of the SERS immunoassay is further demonstrated by successful detection of sE-cadherin and sN-cadherin in metastatic stage IV breast cancer patient plasma samples. ...Continue Reading

References

Nov 14, 2003·Cancer Cell International·Nives Pećina-Slaus
Sep 7, 2004·The International Journal of Developmental Biology·Lara D M Derycke, Marc E Bracke
Sep 26, 2006·International Journal of Cancer. Journal International Du Cancer·Lara DeryckeMarc Bracke
Oct 24, 2007·Clinical & Experimental Metastasis·Olivier De WeverMarc Bracke
Dec 7, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Karsten GravdalLars A Akslen
May 8, 2008·Clinical & Experimental Metastasis·T BlickE W Thompson
Jul 24, 2008·Histochemistry and Cell Biology·Olivier De WeverGeert Berx
Oct 27, 2009·Future Oncology·Michael K WendtWilliam P Schiemann
Jun 15, 2011·Molecular Cancer Research : MCR·Andrew J ArmstrongMariano A Garcia-Blanco
Jul 20, 2012·Expert Review of Proteomics·Masae KuboniwaMurray Hackett
Dec 15, 2012·Critical Reviews in Oncogenesis·Thomas N Seyfried, Leanne C Huysentruyt
Feb 22, 2014·Nature Reviews. Molecular Cell Biology·Samy LamouilleRik Derynck
Apr 9, 2015·Clinical and Translational Medicine·Sarah HeerbothSibaji Sarkar
Jul 2, 2016·Cell·M Angela NietoJean Paul Thiery
Sep 11, 2016·Advances in Cancer Research·M E MenezesP B Fisher
Sep 29, 2017·Journal of Cancer Metastasis and Treatment·Maozhen Tian, William P Schiemann
Jan 13, 2018·Nature Reviews. Cancer·Thomas BrabletzRobert A Weinberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.